Home/Filings/4/0001019056-20-000295

4//SEC Filing

ARDSLEY ADVISORY PARTNERS LP 4

Accession 0001019056-20-000295

CIK 0001441693other

View on SEC.gov Company Profile

Filed

May 3, 8:00 PM ET

Accepted

May 4, 4:52 PM ET

Size

50.9 KB

Accession

0001019056-20-000295

Insider Transaction Report

Form 4

Period: 2020-04-29

MARRONE BIO INNOVATIONS INCMBII

Ardsley Advisory Partners GP LLC

Other

Transactions

Award
Warrant
2020-04-29+741,617→ 741,617 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (741,617 underlying)
Award
Warrant
2020-04-29+343,341→ 343,341 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-09-15→ Common Stock (343,341 underlying)
Exercise/Conversion
Warrant
2020-04-29−2,127,498→ 0 total(indirect: See Footnotes)
Exercise: $1.00Exp: 2021-12-31→ Common Stock (2,127,498 underlying)
Exercise/Conversion
Warrant
2020-04-29−3,205,835→ 0 total(indirect: See Footnotes)
Exercise: $1.75Exp: 2023-01-01→ Common Stock (3,205,835 underlying)
Award
Warrant
2020-04-29+429,176→ 429,176 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Award
Warrant
2020-04-29+1,648,037→ 1,648,037 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (1,648,037 underlying)
Exercise/Conversion
Common Stock
2020-05-01+429,176→ 13,959,758 total(indirect: See Footnotes)
Award
Warrant
2020-04-29+618,014→ 618,014 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-12-15→ Common Stock (618,014 underlying)
Exercise/Conversion
Warrant
2020-05-01−429,176→ 0 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)

Ardsley Partners Advanced Healthcare Fund, L.P.

10% Owner

Transactions

Exercise/Conversion
Warrant
2020-05-01−429,176→ 0 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Exercise/Conversion
Warrant
2020-04-29−3,205,835→ 0 total(indirect: See Footnotes)
Exercise: $1.75Exp: 2023-01-01→ Common Stock (3,205,835 underlying)
Award
Warrant
2020-04-29+343,341→ 343,341 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-09-15→ Common Stock (343,341 underlying)
Exercise/Conversion
Common Stock
2020-05-01+429,176→ 13,959,758 total(indirect: See Footnotes)
Exercise/Conversion
Warrant
2020-04-29−2,127,498→ 0 total(indirect: See Footnotes)
Exercise: $1.00Exp: 2021-12-31→ Common Stock (2,127,498 underlying)
Award
Warrant
2020-04-29+1,648,037→ 1,648,037 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (1,648,037 underlying)
Award
Warrant
2020-04-29+618,014→ 618,014 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-12-15→ Common Stock (618,014 underlying)
Award
Warrant
2020-04-29+429,176→ 429,176 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Award
Warrant
2020-04-29+741,617→ 741,617 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (741,617 underlying)

Ardsley Duckdive Fund, L.P.

10% Owner

Transactions

Exercise/Conversion
Warrant
2020-04-29−2,127,498→ 0 total(indirect: See Footnotes)
Exercise: $1.00Exp: 2021-12-31→ Common Stock (2,127,498 underlying)
Award
Warrant
2020-04-29+343,341→ 343,341 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-09-15→ Common Stock (343,341 underlying)
Exercise/Conversion
Common Stock
2020-05-01+429,176→ 13,959,758 total(indirect: See Footnotes)
Exercise/Conversion
Warrant
2020-05-01−429,176→ 0 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Exercise/Conversion
Warrant
2020-04-29−3,205,835→ 0 total(indirect: See Footnotes)
Exercise: $1.75Exp: 2023-01-01→ Common Stock (3,205,835 underlying)
Award
Warrant
2020-04-29+741,617→ 741,617 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (741,617 underlying)
Award
Warrant
2020-04-29+429,176→ 429,176 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Award
Warrant
2020-04-29+1,648,037→ 1,648,037 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (1,648,037 underlying)
Award
Warrant
2020-04-29+618,014→ 618,014 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-12-15→ Common Stock (618,014 underlying)

ARDSLEY ADVISORY PARTNERS

10% Owner

Transactions

Award
Warrant
2020-04-29+429,176→ 429,176 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Award
Warrant
2020-04-29+343,341→ 343,341 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-09-15→ Common Stock (343,341 underlying)
Award
Warrant
2020-04-29+618,014→ 618,014 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-12-15→ Common Stock (618,014 underlying)
Exercise/Conversion
Warrant
2020-04-29−2,127,498→ 0 total(indirect: See Footnotes)
Exercise: $1.00Exp: 2021-12-31→ Common Stock (2,127,498 underlying)
Exercise/Conversion
Warrant
2020-04-29−3,205,835→ 0 total(indirect: See Footnotes)
Exercise: $1.75Exp: 2023-01-01→ Common Stock (3,205,835 underlying)
Award
Warrant
2020-04-29+1,648,037→ 1,648,037 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (1,648,037 underlying)
Exercise/Conversion
Common Stock
2020-05-01+429,176→ 13,959,758 total(indirect: See Footnotes)
Award
Warrant
2020-04-29+741,617→ 741,617 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (741,617 underlying)
Exercise/Conversion
Warrant
2020-05-01−429,176→ 0 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)

ARDSLEY PARTNERS I LP

10% Owner

Transactions

Award
Warrant
2020-04-29+1,648,037→ 1,648,037 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (1,648,037 underlying)
Exercise/Conversion
Common Stock
2020-05-01+429,176→ 13,959,758 total(indirect: See Footnotes)
Award
Warrant
2020-04-29+429,176→ 429,176 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Award
Warrant
2020-04-29+741,617→ 741,617 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (741,617 underlying)
Exercise/Conversion
Warrant
2020-04-29−3,205,835→ 0 total(indirect: See Footnotes)
Exercise: $1.75Exp: 2023-01-01→ Common Stock (3,205,835 underlying)
Award
Warrant
2020-04-29+618,014→ 618,014 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-12-15→ Common Stock (618,014 underlying)
Exercise/Conversion
Warrant
2020-05-01−429,176→ 0 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Exercise/Conversion
Warrant
2020-04-29−2,127,498→ 0 total(indirect: See Footnotes)
Exercise: $1.00Exp: 2021-12-31→ Common Stock (2,127,498 underlying)
Award
Warrant
2020-04-29+343,341→ 343,341 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-09-15→ Common Stock (343,341 underlying)

HEMPLEMAN PHILIP J

10% Owner

Transactions

Award
Warrant
2020-04-29+1,648,037→ 1,648,037 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (1,648,037 underlying)
Award
Warrant
2020-04-29+618,014→ 618,014 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-12-15→ Common Stock (618,014 underlying)
Award
Warrant
2020-04-29+429,176→ 429,176 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Exercise/Conversion
Common Stock
2020-05-01+429,176→ 13,959,758 total(indirect: See Footnotes)
Award
Warrant
2020-04-29+343,341→ 343,341 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-09-15→ Common Stock (343,341 underlying)
Award
Warrant
2020-04-29+741,617→ 741,617 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (741,617 underlying)
Exercise/Conversion
Warrant
2020-05-01−429,176→ 0 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Exercise/Conversion
Warrant
2020-04-29−2,127,498→ 0 total(indirect: See Footnotes)
Exercise: $1.00Exp: 2021-12-31→ Common Stock (2,127,498 underlying)
Exercise/Conversion
Warrant
2020-04-29−3,205,835→ 0 total(indirect: See Footnotes)
Exercise: $1.75Exp: 2023-01-01→ Common Stock (3,205,835 underlying)

Ardsley Partners Renewable Energy Fund, L.P.

10% Owner

Transactions

Exercise/Conversion
Common Stock
2020-05-01+429,176→ 13,959,758 total(indirect: See Footnotes)
Exercise/Conversion
Warrant
2020-04-29−2,127,498→ 0 total(indirect: See Footnotes)
Exercise: $1.00Exp: 2021-12-31→ Common Stock (2,127,498 underlying)
Exercise/Conversion
Warrant
2020-04-29−3,205,835→ 0 total(indirect: See Footnotes)
Exercise: $1.75Exp: 2023-01-01→ Common Stock (3,205,835 underlying)
Award
Warrant
2020-04-29+429,176→ 429,176 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Award
Warrant
2020-04-29+1,648,037→ 1,648,037 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (1,648,037 underlying)
Award
Warrant
2020-04-29+741,617→ 741,617 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (741,617 underlying)
Award
Warrant
2020-04-29+618,014→ 618,014 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-12-15→ Common Stock (618,014 underlying)
Exercise/Conversion
Warrant
2020-05-01−429,176→ 0 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Award
Warrant
2020-04-29+343,341→ 343,341 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-09-15→ Common Stock (343,341 underlying)

Ardsley Partners Fund II, L.P.

10% Owner

Transactions

Exercise/Conversion
Common Stock
2020-05-01+429,176→ 13,959,758 total(indirect: See Footnotes)
Exercise/Conversion
Warrant
2020-04-29−3,205,835→ 0 total(indirect: See Footnotes)
Exercise: $1.75Exp: 2023-01-01→ Common Stock (3,205,835 underlying)
Award
Warrant
2020-04-29+741,617→ 741,617 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-03-15→ Common Stock (741,617 underlying)
Exercise/Conversion
Warrant
2020-05-01−429,176→ 0 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Exercise/Conversion
Warrant
2020-04-29−2,127,498→ 0 total(indirect: See Footnotes)
Exercise: $1.00Exp: 2021-12-31→ Common Stock (2,127,498 underlying)
Award
Warrant
2020-04-29+429,176→ 429,176 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-05-01→ Common Stock (429,176 underlying)
Award
Warrant
2020-04-29+1,648,037→ 1,648,037 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-12-15→ Common Stock (1,648,037 underlying)
Award
Warrant
2020-04-29+618,014→ 618,014 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2021-12-15→ Common Stock (618,014 underlying)
Award
Warrant
2020-04-29+343,341→ 343,341 total(indirect: See Footnotes)
Exercise: $0.75From: 2020-04-29Exp: 2020-09-15→ Common Stock (343,341 underlying)

Footnotes (5)

[F1]This Form 4 is being filed by Ardsley Advisory Partners LP (the "Advisor") on behalf of itself and Ardsley Advisory Partners GP LLC (the "Advisor General Partner"), Ardsley Partners I GP LLC (the "General Partner"), Ardsley Partners Renewable Energy Fund, L.P. (the "Renewable Energy Fund"), Ardsley Partners Advanced Healthcare Fund, L.P. (the "Advanced Healthcare Fund"), Ardsley Partners Fund II, L.P. (the "Fund II"), Ardsley Duckdive Fund, L.P. (the "Duckdive Fund"), and Philip J. Hempleman ("Hempleman" and, together with the Advisor, the Advisor General Partner, the General Partner, the Renewable Energy Fund, the Advanced Healthcare Fund, the Fund II, and the Duckdive Fund, the "Reporting Persons").
[F2](Footnote 1 continued). The Advisor General Partner serves as general partner to the Advisor. The General Partner serves as general partner to the Renewable Energy Fund, the Advanced Healthcare Fund, and the Fund II. Hempleman services as managing member to the Advisor, the Advisor General Partner, and the General Partner, and serves as the general partner to the Duckdive Fund
[F3]As previously disclosed, the Reporting Persons entered into a Warrant Amendment and Plan of Reorganization dated as of August 6, 2019 (the "Agreement"), among the Issuer, the Renewable Energy Fund and certain parties thereto, in which the parties have agreed to extend the expiration date under the Warrants from December 31, 2020 to December 31, 2021.
[F4]On April 29, 2020, the Reporting Persons entered into a Warrant Exchange Agreement (the "Warrant Exchange Agreement") among the Issuer, the Renewable Energy Fund and certain parties thereto, pursuant to which Renewable Energy Fund exchanged all of the warrants to purchase Issuer Common Stock held by it for five tranches of new warrants ("New Warrants") to purchase Common Stock of the Issuer, totaling 3,780,185 New Warrants in the aggregate. Each New Warrant received by Renewable Energy Fund from the Issuer pursuant to the Warrant Exchange Agreement has an exercise price of $0.75.
[F5]In accordance with Instruction 4(b)(iv) of Form 4, the entire amount of the Issuer's securities held by the Reporting Persons is reported herein. Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either the Advisor, the Advisor General Partner, the General Partner, or Hempleman are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.

Documents

2 files

Issuer

MARRONE BIO INNOVATIONS INC

CIK 0001441693

→

Entity typeother

IncorporatedNY

Related Parties

filerCIK 0000900529

Filing Metadata

Form type: 4
Filed: May 3, 8:00 PM ET
Accepted: May 4, 4:52 PM ET
Size: 50.9 KB

View on SEC.gov